Our vision is to deliver a new brand of targeted medicines that will revolutionize healthcare
A new approach to fighting cancer and inflammatory disease
D5Pharma’s next-generation screening technique allows us to identify DNA aptamers that have functional characteristics specific to critical therapeutic targets
Read more about our unique approach in these academic publications
Our findings point to the importance of a specific region of CEA in cancer progression.
D5’s scientists have shown that MetVax can actively prevent tumor implantation.
D5Pharma’s most recent publication on PEG:CCS13: Prodeus, et al., Molecular Therapy Nucleic Acids (2018) 12, 350.